
Albert Q Lam MD
Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease
Associate Physician, Brigham and Women's Hospital
Join to View Full Profile
55 Fruit StBoston, MA 02114
Phone+1 617-726-5050
Fax+1 617-724-1122
Dr. Lam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2007 - 2011
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2007
Northwestern University The Feinberg School of MedicineClass of 2004
Certifications & Licensure
NH State Medical License 2022 - 2028
MA State Medical License 2007 - 2027
ME State Medical License 2020 - 2026
IL State Medical License 2022 - 2026
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
Publications & Presentations
PubMed
- 42 citationsParaprotein–Related Kidney Disease: Glomerular Diseases Associated with ParaproteinemiasShveta S. Motwani, Leal Herlitz, Divya Monga, Kenar D. Jhaveri, Albert Q. Lam
Clinical Journal of the American Society of Nephrology. 2016-08-15 - 654 citationsNephron organoids derived from human pluripotent stem cells model kidney development and injuryRyuji Morizane, Albert Q. Lam, Benjamin S. Freedman, Seiji Kishi, M. Todd Valerius
Nature Biotechnology. 2015-11-01 - 553 citationsModelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.Benjamin S. Freedman, Craig R. Brooks, Albert Q. Lam, Hongxia Fu, Ryuji Morizane
Nature Communications. 2015-10-23
Press Mentions
Research Findings Point to New Therapeutic Approach for Common Cause of Kidney FailureFebruary 10th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









